These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22018300)

  • 1. Biomonitoring and biomarker-guided therapy: the next step in heart failure and biomarker research.
    Maisel A
    J Am Coll Cardiol; 2011 Oct; 58(18):1890-2. PubMed ID: 22018300
    [No Abstract]   [Full Text] [Related]  

  • 2. B-type natriuretic peptide (BNP) and N-terminal proBNP in patients with end-stage heart failure supported by a left ventricular assist device.
    Kemperman H; van den Berg M; Kirkels H; de Jonge N
    Clin Chem; 2004 Sep; 50(9):1670-2. PubMed ID: 15331503
    [No Abstract]   [Full Text] [Related]  

  • 3. Natriuretic peptides in heart failure: their role in daily practice.
    Loboz-Grudzień K; Jaroch J
    Cardiol J; 2009; 16(1):1-3. PubMed ID: 19130409
    [No Abstract]   [Full Text] [Related]  

  • 4. What is the role of B-type natriuretic peptide in detecting heart failure in critically ill, mechanically ventilated patients?
    Colombo R
    Minerva Anestesiol; 2009 Apr; 75(4):175-7. PubMed ID: 19308015
    [No Abstract]   [Full Text] [Related]  

  • 5. Understanding "diastolic heart failure": the tip of the iceberg.
    Nishimura RA; Jaber W
    J Am Coll Cardiol; 2007 Feb; 49(6):695-7. PubMed ID: 17291935
    [No Abstract]   [Full Text] [Related]  

  • 6. Direct comparison of transcardiac difference between brain natriuretic peptide (BNP) and N-terminal pro-BNP in patients with chronic heart failure.
    Tsutamoto T; Sakai H; Ishikawa C; Fujii M; Tanaka T; Yamamoto T; Takashima H; Ohnishi M; Wada A; Horie M
    Eur J Heart Fail; 2007; 9(6-7):667-73. PubMed ID: 17360233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Japanese-Western consensus meeting on biomarkers.
    Maisel AS; Nakao K; Ponikowski P; Peacock WF; Yoshimura M; Suzuki T; Tsutamoto T; Filippatos GS; Saito Y; Seino Y; Minamino N; Hirata Y; Mukoyama M; Nishikimi T; Nagai R
    Int Heart J; 2011; 52(5):253-65. PubMed ID: 22008432
    [No Abstract]   [Full Text] [Related]  

  • 8. [Biomarkers in heart failure: BNP and NT-proBNP].
    Ho CC; Liu CC
    Hu Li Za Zhi; 2009 Oct; 56(5):16-22. PubMed ID: 19760573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased N-terminal-pro-B-type natriuretic peptide levels in patients with appropriate implantable defibrillator therapies.
    Arnaldo FJ; Anatoliotakis N; Palacio C; Nabert DR; Hsu SS
    Heart Lung; 2009; 38(1):10-6. PubMed ID: 19150526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NT-proB natriuretic peptide, risk factors and asymptomatic left ventricular dysfunction: results of the SCReening Evaluation of the Evolution of New Heart Failure study (SCREEN-HF).
    McGrady M; Reid CM; Shiel L; Wolfe R; Boffa U; Liew D; Campbell DJ; Prior D; Stewart S; Krum H
    Int J Cardiol; 2013 Oct; 169(2):133-8. PubMed ID: 24080362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of N-terminal pro-brain natriuretic peptide in the early evaluation of cardiovasculardysfunction in critically ill children].
    Chen Y; Yu Y
    Zhonghua Er Ke Za Zhi; 2014 Feb; 52(2):149-52. PubMed ID: 24739730
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of natriuretic peptide testing in guiding chronic heart failure management: review of available data and recommendations for use.
    Januzzi JL
    Arch Cardiovasc Dis; 2012 Jan; 105(1):40-50. PubMed ID: 22369917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Natriuretic peptides as cardiac markers in clinical practice].
    Veien KT; Jensen JK; Hildebrandt P; Gøtze JP; Nielsen OW; Køber L
    Ugeskr Laeger; 2010 Jul; 172(30):2111-6. PubMed ID: 20654278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials.
    Felker GM; Hasselblad V; Hernandez AF; O'Connor CM
    Am Heart J; 2009 Sep; 158(3):422-30. PubMed ID: 19699866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac resynchronization therapy and B-type natriuretic peptide in heart failure.
    Huang DJ
    Chin Med J (Engl); 2009 Mar; 122(6):608-9. PubMed ID: 19323919
    [No Abstract]   [Full Text] [Related]  

  • 16. Invited commentary.
    Raman J
    Ann Thorac Surg; 2009 Sep; 88(3):726. PubMed ID: 19699886
    [No Abstract]   [Full Text] [Related]  

  • 17. Natriuretic peptide-guided management of acutely destabilized heart failure: rationale and treatment algorithm.
    Bhardwaj A; Januzzi JL
    Crit Pathw Cardiol; 2009 Dec; 8(4):146-50. PubMed ID: 19952548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical utility of brain natriuretic peptide in paediatric left ventricular failure.
    Mangat J; Carter C; Riley G; Foo Y; Burch M
    Eur J Heart Fail; 2009 Jan; 11(1):48-52. PubMed ID: 19147456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A direct comparison of the natriuretic peptides and their relationship to survival in chronic heart failure of a presumed non-ischaemic origin.
    Stanton E; Hansen M; Wijeysundera HC; Kupchak P; Hall C; Rouleau JL;
    Eur J Heart Fail; 2005 Jun; 7(4):557-65. PubMed ID: 15921795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-terminal B-type natriuretic peptide and the association with left ventricular diastolic function in a population at high risk of incident heart failure: results of the SCReening Evaluationof the Evolution of New-Heart Failure Study (SCREEN-HF).
    McGrady M; Reid CM; Shiel L; Wolfe R; Boffa U; Liew D; Campbell DJ; Prior D; Krum H
    Eur J Heart Fail; 2013 May; 15(5):573-80. PubMed ID: 23338855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.